Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors. (Q53650236)

16 May 2018

title

Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors. (English)

1 reference

16 May 2018

author name string

Fraser CJ

1

1 reference

16 May 2018

Weigel BJ

2

1 reference

16 May 2018

Perentesis JP

3

1 reference

16 May 2018

Dusenbery KE

4

1 reference

16 May 2018

DeFor TE

5

1 reference

16 May 2018

Baker KS

6

1 reference

16 May 2018

Verneris MR

7

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 January 2006

1 reference

16 May 2018

Bone Marrow Transplantation

published in

1 reference

16 May 2018

volume

37

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

175-181

1 reference

16 May 2018

High-dose therapy with autologous stem cell rescue for pediatric sarcomas

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Dose-response relationship in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Survival after recurrence of Ewing's sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Megatherapy and stem cell transplantation for Ewing's family of tumors: a critical review of current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

High-dose chemotherapy for solid tumors: results of the EBMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Desmoplastic small cell tumor: a report of three cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Successful dose-intensive treatment of desmoplastic small round cell tumor in three children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

Dose: a critical factor in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

7 January 2021

Autologous stem cell transplantation for high-risk pediatric solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

7 January 2021

High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

7 January 2021

High-dose chemotherapy in children with metastatic hepatoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

7 January 2021

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

7 January 2021

High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

7 January 2021

Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705224

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705224

1 reference

16 May 2018

1 reference

16 May 2018